NCT05751876View on ClinicalTrials.gov

Dienogest in Perimenopausal Women With Adenomyosis

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
AdenomyosisMedication Adherence
Interventions
DRUG

Dienogest

Dienogest 2mg was prescribed once per day orally

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT05751876 - Dienogest in Perimenopausal Women With Adenomyosis | Biotech Hunter | Biotech Hunter